These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12533256)

  • 41. ABC of breast diseases: breast cancer.
    Sainsbury JR; Anderson TJ; Morgan DA
    BMJ; 2000 Sep; 321(7263):745-50. PubMed ID: 10999911
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
    Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
    Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does the patient's opinion differ from the clinicians' regarding breast cosmesis after BCT?
    Parmar V; Nadkarni MS; Kakade A; Hawaldar R; Badwe RA
    Breast J; 2010; 16(1):103-4. PubMed ID: 19929893
    [No Abstract]   [Full Text] [Related]  

  • 44. Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.
    Krug D; Baumann R; Budach W; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Hehr T; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2018 Sep; 194(9):797-805. PubMed ID: 29974132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tumor size and histological grading of stage 1 breast cancer. Prognostic and therapeutic significance].
    Gundersen S; Bøhler P; Hannisdal E; Høst H
    Tidsskr Nor Laegeforen; 1996 Jan; 116(2):222-5. PubMed ID: 8633328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
    Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
    Benson JR
    J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
    [No Abstract]   [Full Text] [Related]  

  • 48. [Radiotherapy for the rest of the breast as a prerequisite for limited surgery?].
    Wannenmacher M; von Fournier D; Anton HW
    Chirurg; 1992 Jun; 63(6):491-4. PubMed ID: 1643986
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Abdel-Rahman O
    Clin Breast Cancer; 2018 Dec; 18(6):504-510. PubMed ID: 30115454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomarkers in early breast cancer and beyond: who needs all those tests?
    Storz-Pfennig P; Wolf K
    Lancet Oncol; 2014 Aug; 15(9):919-20. PubMed ID: 25079097
    [No Abstract]   [Full Text] [Related]  

  • 51. Quality of life assessment.
    Shimozuma K
    Breast Cancer; 2002; 9(2):100-6. PubMed ID: 12016388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is breast saving therapy of breast carcinoma without postoperative radiotherapy justified?].
    Schön M; Liebeskind U; Peek U; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():105-7. PubMed ID: 9101779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approach and management of primary ectopic breast carcinoma in the axilla: where are we? A comprehensive historical literature review.
    Visconti G; Eltahir Y; Van Ginkel RJ; Bart J; Werker PM
    J Plast Reconstr Aesthet Surg; 2011 Jan; 64(1):e1-11. PubMed ID: 20934398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sector resection for stage I breast cancer.
    Mokbel K; Athow A; Kouriefs C; Leris C; Williams N; Carpenter R
    J Clin Oncol; 2000 Feb; 18(4):942-3. PubMed ID: 10673537
    [No Abstract]   [Full Text] [Related]  

  • 55. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
    Bantema-Joppe EJ; Vredeveld EJ; de Bock GH; Busz DM; Woltman-van Iersel M; Dolsma WV; van der Laan HP; Langendijk JA; Maduro JH
    Radiother Oncol; 2013 Aug; 108(2):269-72. PubMed ID: 24055289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting adjuvant chemotherapy: a good idea that needs to be proven!
    Hayes DF
    J Clin Oncol; 2012 Apr; 30(12):1264-7. PubMed ID: 22355050
    [No Abstract]   [Full Text] [Related]  

  • 57. The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.
    Jeffe DB; Pérez M; Cole EF; Liu Y; Schootman M
    Ann Surg Oncol; 2016 Mar; 23(3):735-43. PubMed ID: 26511265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Secondary Angiosarcoma of the Breast after Breast-conserving Therapy].
    Wiebringhaus P; Gröger A; Menke H
    Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):134-8. PubMed ID: 25412244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term results of breast conserving surgery for stages I and II breast cancer: experiences at Osaka Medical Center for Cancer and Cardiovascular Diseases.
    Komoike Y; Motomura K; Inaji H; Kasugai T; Nose T; Koizumi M; Koyama H
    Breast Cancer; 2002; 9(3):248-53. PubMed ID: 12185337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.